Early Access — free while we kick the tires
Mark Voll
Chief Financial Officer
Officer
Latest: RenovoRx, Inc. CFO buying · May 2026
2 filings analyzed
·
1 company
·
Latest 2026-05-21
Never miss a filing from Mark Voll
Watch this insider and we'll alert you the moment they file — at any company.
Companies
| Company |
Buys |
Sells |
Direction |
Holdings |
Latest |
|
RenovoRx, Inc.
RNXT
|
2 |
0 |
Net buying
|
142,380
|
2026-05-21
|
Activity
May 2026
CFO Mark Voll buys 25,000 shares of RNXT at $0.79; stock down 44.1% from 52-week high
Mark Voll, Chief Financial Officer, purchased 25,000 shares at $0.79 on 2026-05-19, increasing his holdings by 21.3% to 142,380 shares. The current price of $0.81 remains 44.1% below the 52-week high of $1.45, with the stock down 19.4% over the past 30 days and 13.9% over 90 days. His prior purchase at this ticker on 2026-03-20 returned -19.0% over 90 days, and his cross-ticker track record shows 1 prior buy with an average 90-day return of -19.0% and a 0.00% win rate. The company is unprofitable with net income of $-3.5M against quarterly revenue of $563.0K, though annual revenue growth reached 2511.6% year-over-year.
March 2026
CFO Mark Voll acquires 97,200 shares of RNXT; cluster buy with 2 others in 14 days
CFO Mark Voll purchased 97,200 shares on 2026-03-20, establishing a first position at the company. This buy occurs as part of a cluster pattern, with 2 other insiders also purchasing within the past 14 days. The company generated $266,000.00 in revenue in its latest quarter but reported a net loss of $-2.9M and carries a market cap of $39.6M. The stock is currently trading at $1.08, down 23.9% from its 52-week high but up 18.3% over 30 days and up 20.6% over 90 days. Simultaneous buying by multiple insiders at an unprofitable company warrants examination of whether the recent price recovery reflects changing fundamentals or represents informed conviction about turnaround prospects.